跳至主要内容
临床试验/PACTR202308727853680
PACTR202308727853680尚未招募Unknown

Effects of Baobab fruit powder on gut and cardiometabolic health in obesity – a randomised placebo-controlled trial

South African Medical Research Council0 个研究点目标入组 50 人开始时间: 2023年7月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Ability to sign informed consent
  • Age between 30 and 45 years
  • BMI = 30 kg/m2
  • Weight stable (less than 5 kg weight change in the last 6 months)

排除标准

  • History of gastrointestinal diseases (e.g. irritable bowel syndrome, coeliac disease, Crohn’s disease, Ulcerative Colitis) and gastrointestinal surgery
  • Current smoker (including e-cigarettes) or user of chewing tobacco
  • Current bacterial or viral infection
  • Pregnancy or breastfeeding
  • Regular use of chronic medication (prescription medication for obesity, chronic non-communicable and infectious diseases, immunosuppressants, frequent use of over-the-counter drugs such as non-steroidal anti-inflammatory drugs and laxatives)
  • Known chronic diseases (with or without treatment with prescription medication) or screen-detected diseases, e.g.:
  • -> autoimmune diseases
  • ->hypertension (BP >140/90 mm Hg);
  • ->Type 1 or Type 2 diabetes (FBG > 7 mmol/l)
  • ->dyslipidaemia (TG >1.7 mmol/l, LDL > 3.0 mmol/l)
  • ->reproductive diseases (e.g. endometriosis or polycystic ovary syndrome)
  • ->thyroid diseases
  • Allergies, e.g. known allergy to baobab (Martini et al., 2019), and food intolerances (e.g. sugar alcohol intolerance)
  • Oral antibiotic use, fibre, pre- and/or probiotic supplement use in the preceding 3 months

研究者

发起方
South African Medical Research Council

相似试验

Effects of Baobab fruit powder on gut and... | 临床试验